Tocilizumab
Tracked across 2 events · 16 articles · First seen May 20, 2026 · Last active May 29, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
A University of Bristol-led clinical trial, published in JAMA Psychiatry, suggests that Tocilizumab>>>, an anti-inflammatory drug typically used for conditions like Rheumatoid arthritis, may offer a new treatment pathway for difficult-to-treat Depression (mood)>>>. The small…
Impact: Tocilizumab>>> is the anti-inflammatory drug being investigated as a potential new treatment for difficult-to-treat depression, showing promising results in the pilot study.
May 20, 2026 · 9 articles
Tech
Dassault Systèmes — Medidata Solutions, a Dassault Systèmes brand, presented two pivotal research abstracts at the American Society of Clinical Oncology 2026 Annual Meeting. The research, conducted by the Dassault Systèmes — Medidata Solutions Research…
Impact: Tocilizumab's efficacy in resolving CAR T-induced Cytokine Release Syndrome was definitively validated by Dassault Systèmes — Medidata Solutions's collaborative study, confirming its importance as a treatment.
May 29, 2026 · 7 articles
100
Tocilizumab eased symptoms Depression (mood)Tocilizumab shows promise...
90
Dassault Systèmes — Medidata Solutions verified efficacy TocilizumabMedidata Presents Oncology...
NEWSDESK
Track Tocilizumab live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard